| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |